Mizuho Medy Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values JPY Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
39
41
76
266
235
Total Accounts Receivable
1,454
1,467
2,033
2,103
2,228
Inventories
593
868
747
793
1,151
Other Current Assets
38
32
62
65
145
Total Current Assets
2,124
2,409
2,917
3,227
3,760
Net Property, Plant & Equipment
888
884
924
940
1,602
Total Investments and Advances
8
8
8
8
8
Intangible Assets
6
5
6
8
15
Other Assets
9
10
9
10
9
Total Assets
3,218
3,491
4,042
4,378
5,583
ST Debt & Current Portion LT Debt
657
353
461
82
Accounts Payable
392
389
341
459
Income Tax Payable
137
58
133
169
Other Current Liabilities
242
253
394
453
Total Current Liabilities
1,428
1,053
1,329
1,163
Long-Term Debt
88
268
185
103
Provision for Risks & Charges
542
580
631
675
Deferred Taxes
183
174
178
185
Total Liabilities
2,058
1,901
2,145
1,941
Common Equity (Total)
1,160
1,590
1,897
2,437
Total Shareholders' Equity
1,160
1,590
1,897
2,437
Total Equity
1,160
1,590
1,897
2,437
Liabilities & Shareholders' Equity
3,218
3,491
4,042
4,378

About Mizuho Medy Co.

View Profile
Address
5-4 Fujinoki-machi
Tosu Saga 841
Japan
Employees -
Website http://www.mizuho-m.co.jp
Updated 07/08/2019
Mizuho Medy Co., Ltd. engages in research and development, manufacture and distribution of in-vitro diagnostic products. It operates through the Hospital and Practitioner, and Over-the-Counter (OTC) and Other fields divisions. The Hospital and Practitioner field division covers the manufacture and distribution of biochemical test drugs and immune serun test drugs for medical institutions.